SpineguardXPAR:ALSGD +1.83% 14-Day RSI is 42.81 as of Jul. 11, 2026. The stock has 4 warning signs investors should review. Among 868 Medical Devices & Instruments companies, Spineguard ranks better than 76.27% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-07-11), Spineguard's 14-Day RSI is 42.81.
The industry rank for Spineguard's 14-Day RSI or its related term are showing as below:
XPAR:ALSGD's 14-Day RSI is ranked better than 76.27% of 868
companies
in the Medical Devices & Instruments industry
Industry Median: 47.05
vs XPAR:ALSGD: 42.81
Spineguard (XPAR:ALSGD) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Spineguard 14-Day RSI Related Terms
XPAR:ALSGD vs ABT, SYK, MDT: 14-Day RSI Comparison
For the Medical Devices subindustry, Spineguard's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Spineguard 14-Day RSI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Spineguard's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Spineguard's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Spineguard (XPAR:ALSGD) has a 14-Day RSI of 42.81 as of Jul. 11, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Spineguard and its competitors. According to the industry distribution chart, Spineguard ranks #206 out of 868 companies in the Medical Devices & Instruments industry, placing it in the top 23.7%.
Is Spineguard's 14-Day RSI too high?
Spineguard's current 14-Day RSI is 42.81. The Medical Devices & Instruments industry median 14-Day RSI is 47.05. Spineguard's value of 42.81 is 9% below this industry median. Based on the distribution chart, Spineguard ranks #206 out of 868 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does Spineguard's 14-Day RSI compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Spineguard ranks #206 out of 868 companies for 14-Day RSI. This places Spineguard in the top 24% of its industry — outperforming the majority of peers. The industry median 14-Day RSI is 47.05. Spineguard's value of 42.81 is 9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Medical Devices & Instruments company?
The median 14-Day RSI among Medical Devices & Instruments companies is 47.05, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Spineguard's current 14-Day RSI of 42.81 is 9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Spineguard and its competitors. For the Medical Devices & Instruments industry, the median 14-Day RSI is 47.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Spineguard's current 14-Day RSI is 42.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spineguard stock overvalued right now?
Based on GuruFocus' analysis, Spineguard (XPAR:ALSGD) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.10, compared to a current price of €0.08 — trading 16.5% below its estimated fair value. The current 14-Day RSI is 42.81 and 9% below the Medical Devices & Instruments industry median of 47.05. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Spineguard (XPAR:ALSGD), the current 14-Day RSI is 42.81 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Spineguard is engaged in the design and production of medical instruments used for spinal surgeries. It is deploying its proprietary radiation-free real time sensing technology DSG (Dynamic Surgical Guidance) to secure and streamline the placement of implants in the skeleton. It designs, develops and markets medical devices embedding its technology. The group is developing DSG digital technology for real-time surgical guidance without X-rays to improve the safety and simplify the placement of bone implants, pedicle screws, and smart drills. SpineGuard is extending the applications of its DSG technology to anterior scoliosis treatment, sacroiliac joint fusion, and dental implantology.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:ALSGD has been successfully added to your